Connect with RxStrategies at the 2019 Fall Hospital Pharmacy Conference
RxStrategies will be at the Fall Hospital Pharmacy (HCP) Conference on October 28-30 in Kansas City, MO. Team members Justin Rolling and Rhodie Smith will be networking with peers, attending educational sessions and sharing their expertise in 340B solutions. Learn more about the conference here. Contact us to connect during the conference and learn…
Meet Us at Cardinal Health’s RBC 2019
Todd Hudnall and Skip Devanny will represent RxStrategies at Cardinal Health’s RBC 2019 in Nashville, July 17-20. Learn more about RBC by visiting their site. Contact us to connect during the conference, and stop by booth 118 to learn about how our comprehensive solutions help keep your 340B program on the right track.
Meet Us at the 2019 CPS/PSI Annual Conference in May
Ryen Brumbeloe and Todd Hudnall will attend and exhibit at the Comprehensive Pharmacy Systems/Pharmacy Systems, Inc. (CPS) Annual Meeting & Vendor Expo in Indianapolis, IN. There, over hundreds of pharmacy decision makers will connect and gain insight into the latest industry news. Visit us on May 16 to network with our team members. Contact us…
Achieve more with advanced analytics
Did you know? Mixed-use inventory virtualization and replenishment platforms through RxStrategies are secure, user-friendly, highly customizable and work with all wholesalers and EHRs. In fact, RxStrategies’ integration of the Medi-Span drug database minimizes the need for manual NDC and multiplier mapping, while system-logic seamlessly complies with state-level MCO reporting requirements. Real-time drug cost analytics…
Maximize 340B Program Results
RxStrategies prides itself on offering intuitive contract pharmacy management through advanced reporting and analytics. Our conservative approach to 340B maximizes program results by ensuring more of the 340B savings remain with Covered Entity (CE) through a simple, all-inclusive fee. Another way our contract pharmacy solution is able to maximize results is through our audit-proven eligibility…
Maintain a Compliant 340B Program in Your Hospital
Through RxStrategies’ hospital-focused services, hospitals can manage and track grant funded subsidies, manage 340B product purchases and inventory, participate in P&T committees, manage pharmacies, receive consulting services to improve financial, operational and strategic management and more. The comprehensive solutions that allow hospitals to maintain a compliant 340B program include: Split Billing – Addresses the complexity…
Ensure and Maximize 340B Program Compliance
We assist retail and specialty pharmacies in ensuring 340B program security, efficiency and safety. With this solution, you will be able to maximize compliance, visibility, capture rate, inventory reconciliation and more. Key Elements of Our Enterprise Backbone for Retail and Specialty Pharmacies • Serves as data clearinghouse for all your contracted TPAs (Third Party…
Clinical Insights: October 10, 2017
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Zilretta™ (triamcinolone acetonide extended-release) – October 6, 2017 – Flexion Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) approved Zilretta™ (triamcinolone acetonide extended-release…
Working Together for Program Compliance
Attending the Second Annual Council of Pharmacy Executives and Suppliers (CPES) October 4-5 in Franklin, Tennessee? Our team at RxStrategies can’t wait to connect with leading pharmacy executives in the industry as we work together to ensure 340B Program compliance. Network with any of our team members attending the conference: Skip Devanny – Chief…
Clinical Insights: September 22, 2017
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Solosec™ (secnidazole) – September 18, 2017 – Symbiomix Therapeutics announced the U.S. Food and Drug Administration (FDA) has approved Solosec™ (secnidazole) 2g oral granules for the…
Connect with us at the Pharmacy Systems Inc. Annual Conference!
RxStrategies is proud to be a Level 3 Sponsor for the PSI Annual Meeting. Our team members Todd Hudnall, National Sales Manager, Midwest Region and Jonathan Ghenn, Vice President of Split Billing/Enterprise Sales, will be attending the Pharmacy Systems Inc. Annual Conference October 2-3 in Dublin, Ohio. They look forward to connecting with pharmacy leaders…